Ireland
--:--IST
Recruiting Not applicable

Effect of TENS on Pain and Symptoms in Primary Dysmenorrhea

NCT06741059 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2024-12-20
Last updated
2025-03-20

Condition(s) studied

Dysmenorrhea

Investigational drug(s) / intervention(s)

Transkutanöz Elektriksel Sinir Stimülasyonu - TENS

Transkutanöz Elektriksel Sinir Stimülasyonu - TENS: Transcutaneous Electrical Nerve Stimulation (TENS) has gained popularity in recent years as a non-invasive method for pain management. TENS works by modulating nerve stimulation through low-frequency electrical currents applied to the skin, reducing pain perception. Its potential effectiveness in alleviating menstrual pain has drawn increasing attention as an alternative treatment option

Study summary

The Effect of Transcutaneous Electrical Nerve Stimulation (TENS) on Pain and Menstrual Symptoms in Primary Dysmenorrhea

This study aims to investigate the effectiveness of Transcutaneous Electrical Nerve Stimulation (TENS) in managing pain and alleviating menstrual symptoms in individuals with primary dysmenorrhea. Primary dysmenorrhea is characterized by severe menstrual pain and accompanying symptoms that negatively impact the quality of life and daily functioning. TENS, a non-invasive and drug-free method, is applied to relieve pain by stimulating nerves through electrical impulses. This research evaluates the impact of TENS on both the intensity of menstrual pain and associated symptoms, offering insights into its potential as an alternative or complementary therapeutic approach.

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Aged 18 and above * Have regular menstrual cycles (lasting 3 to 8 days, with a menstrual cycle range of 21 to 35 days) * Have dysmenorrhea pain severity rated 4 or higher on the Visual Analog Scale (VAS) Exclusion Criteria: Women with the following conditions were excluded from the study: * Secondary dysmenorrhea * Using oral contraceptives * Having impaired tissue integrity in the abdominal area * Having previous experience with TENS * Having a history of nerve damage or sensory loss * Having a pacemaker * Having any systemic diseases * Being pregnant or in the postpartum period

Primary outcome measure(s)

  • Transcutaneous Electrical Nerve Stimulation — 3 months
    Transcutaneous Electrical Nerve Stimulation (TENS) is effective in pain management in women with primary dysmenorrhea. The Visual Analog Scale is a scale where the patient can mark their own pain on a ruler that can be used horizontally or vertically, where the pain is evaluated between 0-10. VCS is used to evaluate both the severity of pain and the effectiveness of the treatment/intervention on pain in various populations. An increase in the score indicates an increase in pain.

Trial sites (1)

FacilityCityRegionStatus
Esra Ünal Osmaniye Turkey (Türkiye) Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06741059 on ClinicalTrials.gov ↗ ← All trials in Turkey